Genentech parts ways with global AI head Richard Bonneau

Genentech, the Roche biotech unit, announced that its global head of artificial intelligence for drug discovery, computational biologist Richard Bonneau, has left the company effective immediately.

Bonneau had overseen AI-driven drug discovery programs at Genentech, and his departure is described as a high-profile exit within the industry.

The exit adds to recent leadership changes in pharma AI groups, but the company did not disclose a successor or the reasons for the move.